Nasus Pharma Ltd. (NSRX)

US · Healthcare · Drug Manufacturers - General

$3.53+2.02%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Net profit

$-5.9M

EPS

$-0.54

EPS estimate

$-0.23

EPS came in at -0.54 against a street estimate of -0.23 — a miss of 134.8%.

Market cap

$39.9M

Forward P/E

0.0

P/B

3.63

Book value

$0.94

EPS (TTM)

$-1.13

52-week high

$9.50

52-week low

$1.98

50-day MA

$3.43

200-day MA

$4.28

with an average price target of $19.67.

Insiders

49.16%

Institutions

18.36%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nasus Pharma Ltd. — free to start.

Data updated 2026-09-18.